Showing 1441-1450 of 3305 results for "".
Genesis: Exosomes and the Future of Skin Regeneration from Dr. David Goldberg’s perspective
https://modernaesthetics.com/topics/regenerative-medicine/genesis-exosomes-and-the-future-of-skin-regeneration-from-dr-david-goldbergs-perspective/36204/Modern Aesthetics sat down with David Goldberg, MD, JD, who led the Genesis: Innovations in Aesthetic Regenerative Medicine meeting block focused on Exosomes.Q&A: The Rise of Peptides
https://modernaesthetics.com/ma-issues-index/2024-july-aug/qa-the-rise-of-peptides/35389/Where Are We in 2023? A Q&A On Hair Transplantation
https://modernaesthetics.com/ma-issues-index/2023-sept-oct/where-are-we-in-2023-a-qa-on-hair-transplantation/35320/Robin Unger, MD, and Marc Avram, MD, reveal how they are treating hair loss in their practices today and what they anticipate in the future.Where Are We in 2023? A Q&A on Botulinum Toxins
https://modernaesthetics.com/ma-issues-index/2023-nov-dec/where-are-we-in-2023-a-qa-on-botulinum-toxins/35332/Sue Ellen Cox, MD, describes what she is seeing in the evolving neuromodulators landscapeProfiles in Innovation: David E. Kent, MD
https://modernaesthetics.com/topics/energy-based-devices/profiles-in-innovation-david-e-kent-md/34909/Where Are We in 2023? A Q&A on Non-Invasive Body Contouring
https://modernaesthetics.com/topics/energy-based-devices/where-are-we-in-2023-a-qa-on-non-invasive-body-contouring/35289/The past decade has seen rapid growth in the realm of non-invasive body contouring technologies to reduce small areas of fat, improve muscle tone and the appearance of cellulite, and reduce skin laxity.Where Are We in 2024? A Q&A on Non-Surgical Skin Tightening
https://modernaesthetics.com/ma-issues-index/2024-jan-feb/where-are-we-in-2024-a-qa-on-non-surgical-skin-tightening/35344/Anne Chapas, MD, and Erez Dayan, MD, share insights into the latest developments in non-surgical skin tightening.MATV News Extra: Daxxify Q&A with Dr. Jeffrey Dover
https://modernaesthetics.com/series/matv-news/matv-news-extra-daxxify-qa-with-dr-jeffrey-dover/33704/The FDA has approved Revance Therapeutics’ Daxxify (daxibotulinumtoxinA-lanm) for injection for the temporary improvement of moderate to severe glabellar lines in adults. Dermatologists and clinical trial investigator Jeffrey Dover, MD sat down with MATV News to share insights into the SAKURA PhaseMATV News Extra: A Q&A with Dr. Theda Kontis, AAFPRS President
https://modernaesthetics.com/series/matv-news/matv-news-extra-a-qa-with-dr-theda-kontis-aafprs-president/33711/Theda C. Kontis, MD, FACS the second woman to serves as American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) president, recently sat down with MATV News to discuss her new role and her goals, including continuing to move the academy and foundation forward by further increasing tranHealthcare Q&A: An Aesthetics Perspective on the Affordable Care Act
https://modernaesthetics.com/ma-issues-index/2013-nov-dec/healthcare-qa-an-aesthetics-perspective-on-the-affordable-care-act/34695/